We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
-7.19%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.49B
AUM Growth
-$1.14B
Cap. Flow
-$786M
Cap. Flow %
-52.7%
Top 10 Hldgs %
52.35%
Holding
2,357
New
492
Increased
311
Reduced
506
Closed
984

Top Buys

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$10.5M
2
INDA icon
iShares MSCI India ETF
INDA
+$9.67M
3
IBKC
IBERIABANK Corp
IBKC
+$8.93M
4
HYT icon
BlackRock Corporate High Yield Fund
HYT
+$8.03M
5
AMZN icon
Amazon
AMZN
+$7.15M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$16.7M
2
NFLX icon
Netflix
NFLX
+$15.8M
3
WCG
Wellcare Health Plans, Inc.
WCG
+$15.7M
4
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$15.1M
5
MDCO
Medicines Co
MDCO
+$11.9M

Sector Composition

Rank Sector Weight
1 Technology 6.31%
2 Consumer Discretionary 3.94%
3 Healthcare 3.91%
4 Communication Services 2.7%
5 Financials 2.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNVR
2176
DELISTED
Univar Solutions Inc.
UNVR
– –
-1,581
Closed -$38K
VRAY
2177
DELISTED
ViewRay, Inc.
VRAY
– –
-651
Closed -$3K
ATTO
2178
DELISTED
Atento S.A.
ATTO
– –
-995
Closed -$14K
LSI
2179
DELISTED
Life Storage, Inc.
LSI
– –
-39,053
Closed -$2.82M
BLU
2180
DELISTED
BELLUS Health Inc.
BLU
– –
-466
Closed -$4K
JNCE
2181
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
– –
-4,300
Closed -$38K
MAXR
2182
CALL
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
– –
-5,400
Closed -$85K
AUY
2183
CALL
DELISTED
Yamana Gold, Inc.
AUY
– –
-2,000
Closed -$8K
EVOP
2184
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
– –
-4,481
Closed -$118K
CNCE
2185
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-2,584
Closed -$24K
ALBO
2186
DELISTED
Albireo Pharma Inc
ALBO
– –
-340
Closed -$9K
AVYA
2187
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
– –
-89,294
Closed -$1.21M
BNFT
2188
DELISTED
Benefitfocus, Inc.
BNFT
– –
-100
Closed -$2K
SPNE
2189
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
– –
-2,942
Closed -$35K
ABMD
2190
DELISTED
Abiomed Inc
ABMD
– –
-565
Closed -$96K
CLVS
2191
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-626
Closed -$5.02K
SWCH
2192
DELISTED
Switch, Inc. Class A Common Stock
SWCH
– –
-25,027
Closed -$371K
AGTC
2193
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-147
Closed -$1K
ZEN
2194
CALL
DELISTED
ZENDESK INC
ZEN
– –
-1,500
Closed -$115K
ZEN
2195
DELISTED
ZENDESK INC
ZEN
– –
-1,514
Closed -$116K
TEN
2196
CALL
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
– –
-600
Closed -$8K
ECOM
2197
DELISTED
CHANNELADVISOR CORPORATION
ECOM
– –
-8,908
Closed -$81K
ZVO
2198
DELISTED
Zovio Inc. Common Stock
ZVO
– –
-210,450
Closed -$434K
AVLR
2199
DELISTED
Avalara, Inc.
AVLR
– –
-575
Closed -$42K
CVET
2200
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-344
Closed -$5K
86 87
88
89 90

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Prelude Capital Management's Q1 2020 Portfolio in Review

As of Q1 2020, Prelude Capital Management held 2,357 positions worth $1.49B, down 43% from $2.63B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Prelude Capital Management withdrew a net $786M in Q1 2020, closing 984 positions and reducing 506 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $16.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, up from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $10.3M.

  • Prelude Capital Management's largest Q1 2020 buy was Vanguard Short-Term Corporate Bond ETF: 130,000 shares worth $10.3M.
  • Prelude Capital Management added most to IBERIABANK Corp in Q1 2020, an estimated $8.93M increase.
  • Prelude Capital Management's biggest Q1 2020 reduction was Netflix, cutting an estimated $15.8M.
  • Prelude Capital Management fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $16.7M.
  • Prelude Capital Management's ten largest holdings make up 52% of its $1.49B portfolio in Q1 2020.
  • Prelude Capital Management opened 492 new positions and closed 984 in Q1 2020.
  • Prelude Capital Management's portfolio value fell 43% quarter-over-quarter to $1.49B.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.